Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
RenovoRx, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security
Class Title | Fee Calculation or Carry Forward Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Proposed
Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||||||
Fees to be Paid | ||||||||||||||||||||||||||||||||||||||||||||||
Equity | Common Stock, par value $0.0001 per share, underlying Underwriter Warrants (Primary Offering)(2) | 457(g) | 198,875 | $ | 10.80 | (3) | $ | 2,147,850 | 0.00011020 | $ | 237 | |||||||||||||||||||||||||||||||||||
Equity | Common Stock, par value $0.0001 per share, underlying Note Warrants (Primary Offering)(4) | 457(g) | 708,820 | $ | 10.80 | (3) | $ | 7,655,256 | 0.00011020 | $ | 843 | |||||||||||||||||||||||||||||||||||
Equity | Common Stock, par value $0.0001 per share, underlying IPO Warrants (Primary Offering)(5) | 457(g) | 1,879,300 | $ | 10.80 | (4) | $ | 20,296,440 | 0.00011020 | $ | 2,237 | |||||||||||||||||||||||||||||||||||
Equity | Common Stock, par value $0.0001 per share (Secondary Offering)(6) | 457(g) | 2,786,995 | - | - | - | - | (7) | ||||||||||||||||||||||||||||||||||||||
Equity | Note Warrants to purchase Common Stock (Secondary Offering)(8) | 457(g) | 708,820 | - | - | - | - | (7) | ||||||||||||||||||||||||||||||||||||||
Fee Previously Paid | ||||||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||||
Total Offering Amounts | $ | 30,099,546 | $ | 3,317 | ||||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | $ | 2,474 | ||||||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | 843 |
(1) | Pursuant to Rule 416(a) under the Securities Act, this Registration Statement shall also cover any additional shares of the Registrant’s common stock (“Common Stock”) that become issuable as a result of any stock dividend, stock split, recapitalization, or other similar transaction effected without the receipt of consideration that results in an increase to the number of outstanding shares of Common Stock, as applicable. | |
(2) | Consists of shares of the Registrant’s Common Stock issuable by the Registrant upon the exercise of Underwriter Warrants (as defined in this Registration Statement). | |
(3) | Calculated pursuant to Rule 457(g) under the Securities Act, based on the exercise price of the warrants. | |
(4) | Consists of shares of the Registrant’s Common Stock issuable by the Registrant upon the exercise of Note Warrants (as defined in this Registration Statement). | |
(5) | Consists of shares of the Registrant’s Common Stock issuable by the Registrant upon the exercise of IPO Warrants (as defined in this Registration Statement), | |
(6) | Consists of an aggregate number of shares of Common Stock registered for resale by the Selling Securityholders named in this Registration Statement, issuable upon the exercise of the Underwriter Warrants, Note Warrants, and IPO Warrants. | |
(7) | Pursuant to Rule 457(g) of the Securities Act, no separate fee is recorded for the warrants and the entire fee is allocated to the underlying Common Stock. | |
(8) | Consists of 708,820 Note Warrants registered for resale by the Selling Securityholders named in this Registration Statement. |
Table 2: Fee Offset Claims and Sources
Registrant of Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | ||||||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||
Fee Offset Claims | ||||||||||||||||||||||||||||||||||||||||
Fee Offset Sources | ||||||||||||||||||||||||||||||||||||||||
Rule 457(p) | ||||||||||||||||||||||||||||||||||||||||
Fee Offset Claims | RenovoRx, Inc. | S-1/A | 333-258071 | (12) | 8/25/21 | $ | 2,474 | Equity | Shares underlying IPO Warrants and Underwriter Warrants included as part of the Units | $ | 22,444,290 | |||||||||||||||||||||||||||||
Fee Offset Claims | RenovoRx, Inc. | S-1 | 333-258071 | (12) | 7/21/21 | $ | 2,474 |